Camp4 CFO granted 215,000 stock options
Camp4 Therapeutics Corp Chief Financial Officer Kelly Gold received a grant of stock options covering 215,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Camp4 Therapeutics Corp Chief Financial Officer Kelly Gold received a grant of stock options covering 215,000 shares of common stock. The options have an exercise price of $4.46 per share and expire in 2036.
The shares underlying the option vest in equal monthly installments over four years from the grant date, meaning the award functions as long-term, time-based compensation rather than an immediate cash transaction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 215,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. The shares underlying the option vest in equal monthly installments over a period of four years commencing from the date of grant.
Key Figures
Key Terms
Stock Option (Right to Buy) financial
exercise price financial
expiration date financial
vest in equal monthly installments financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Camp4 Therapeutics (CAMP) report for its CFO?
What is the exercise price of the Camp4 (CAMP) CFO’s new stock options?
How many Camp4 (CAMP) stock options were granted to CFO Kelly Gold?
When do the Camp4 (CAMP) CFO’s stock options vest?
When do the newly granted Camp4 (CAMP) stock options expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.